Vertex Pharmaceuticals Logo

Vertex Pharmaceuticals

🇺🇸
VRTX
US92532F1003

Vertex Pharmaceuticals, a US-based biopharmaceutical company, develops innovative medicines for people living with serious and rare diseases. The company is a leader in cystic fibrosis treatment and is pioneering therapies for other genetic diseases. Through scientific research, Vertex is improving the lives of patients globally.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
After-Hours
In 25 days

Stock Price

All Dates

Company Information

Name
Vertex Pharmaceuticals
Ticker Symbol
VRTX
ISIN
US92532F1003
Country
🇺🇸
USA